|
|||||
|
Potential good news for herpes sufferers comes after Australian group Starpharma Holdings Ltd recently announced the successful completion of a fourth set of patient trials of VivaGel®, a topical microbicide being developed for the prevention of HIV and HSV-2 herpes virus infection. [...] AlphaVax, the biotechnology company, has signed a $20 million partnership deal with pharmaceutical company Novartis to develop an experimental herpes cure vaccine for the cytomegalovirus, a type of herpes virus. [...] |
|
||||
|
Copyright © 2012 Herpes News - All Rights Reserved Bad Behavior has blocked 77 access attempts in the last 7 days. |
|||||
